Hepatocellular carcinoma cells remodel the pro-metastatic tumour microenvironment through recruitment and activation of fibroblasts via paracrine Egfl7 signaling

por Sun, Bo, Lei, Xiong, Cao, Momo, Li, Yiming, Yang, Lian-Yue
Publicado 2023

Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma

por Yang, Lian-yue, Lu, Wei-qun, Huang, Geng-wen, Wang, Wei
Publicado 2006

GNA14’s interaction with RACK1 inhibits hepatocellular carcinoma progression through reducing MAPK/JNK and PI3K/AKT signaling pathway

por Xu, Cong, Li, Yi-Ming, Sun, Bo, Zhong, Fang-Jing, Yang, Lian-Yue
Publicado 2021

ATE1 Inhibits Liver Cancer Progression through RGS5-Mediated Suppression of Wnt/β-Catenin Signaling

por Xu, Cong, Li, Yi-Ming, Sun, Bo, Zhong, Fang-Jing, Yang, Lian-Yue
Publicado 2021

Piezo1 promoted hepatocellular carcinoma progression and EMT through activating TGF-β signaling by recruiting Rab5c

por Li, Yi-ming, Xu, Cong, Sun, Bo, Zhong, Fang-jing, Cao, Momo, Yang, Lian-yue
Publicado 2022

MicroRNA-424 inhibits Akt3/E2F3 axis and tumor growth in hepatocellular carcinoma

por Yang, Hao, Zheng, Wei, Shuai, Xiao, Chang, Rui-Min, Yu, Lei, Fang, Feng, Yang, Lian-Yue
Publicado 2015

JARID2 promotes invasion and metastasis of hepatocellular carcinoma by facilitating epithelial-mesenchymal transition through PTEN/AKT signaling

por Lei, Xiong, Xu, Jiang-Feng, Chang, Rui-Min, Fang, Feng, Zuo, Chao-Hui, Yang, Lian-Yue
Publicado 2016

Downregulation of castor zinc finger 1 predicts poor prognosis and facilitates hepatocellular carcinoma progression via MAPK/ERK signaling

por Wang, Ji-Long, Yang, Meng-yuan, Xiao, Shuai, Sun, Bo, Li, Yi-Ming, Yang, Lian-Yue
Publicado 2018

NAD(P)HX epimerase downregulation promotes tumor progression through ROS/HIF‐1α signaling in hepatocellular carcinoma

por Sun, Bo, Yu, Lei, Xu, Cong, Li, Yi‐Ming, Zhao, Yan‐Rong, Cao, Mo‐Mo, Yang, Lian‐Yue
Publicado 2021

Serum epidermal growth factor-like domain 7 serves as a novel diagnostic marker for early hepatocellular carcinoma

por Yang, Meng-Yuan, Wu, Fan, Fang, Feng, Yang, Hao, Zhang, Jing-Fan, Chen, Guo-Dong, Yang, Lian-Yue
Publicado 2021

Programmed cell death 10 promotes metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma via PP2Ac-mediated YAP activation

por Sun, Bo, Zhong, Fang-Jing, Xu, Cong, Li, Yi-Ming, Zhao, Yan-Rong, Cao, Mo-Mo, Yang, Lian-Yue
Publicado 2021

Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma

por Lei, Xiong, Li, Yun-feng, Chen, Guo-dong, Ou, Di-peng, Qiu, Xiao-xin, Zuo, Chao-hui, Yang, Lian-Yue
Publicado 2015

Actin‐like 6A predicts poor prognosis of hepatocellular carcinoma and promotes metastasis and epithelial‐mesenchymal transition

por Xiao, Shuai, Chang, Rui‐Min, Yang, Ming‐Yang, Lei, Xiong, Liu, Xiao, Gao, Wen‐Bin, Xiao, Jing‐Lei, Yang, Lian‐Yue
Publicado 2016

YMO1 suppresses invasion and metastasis by inhibiting RhoC signaling and predicts favorable prognosis in hepatocellular carcinoma

por Chang, Rui-Min, Pei, Lei, Fang, Feng, Xu, Jiang-Feng, Yang, Hao, Zuo, Chao-Hui, Zhou, Jian-Hua, Luo, Geng-Qiu, Yang, Lian-Yue
Publicado 2016